1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Healthcare Services Group entered into a Second Amendment to its existing credit agreement with PNC Bank as administrative agent, extending the maturity date to April 7, 2031 and adding a daily SOFR rate option. The filing describes the credit facility as $300 million, and the remaining terms of the agreement stay in effect, so shareholders are mainly seeing a longer debt maturity and added rate flexibility rather than a new obligation of a different kind.
Second Amendment dated April 7, 2026 to the Credit Agreement originally dated December 21, 2018, as amended November 22, 2022
Maturity date extended to April 7, 2031
Added a daily SOFR rate option; PNC Bank, National Association is administrative agent
Filed as Exhibit 10.1; certain schedules and exhibits omitted under Item 601(a)(5) of Regulation S-K
Marathon Petroleum (MPC) entered into a new $5.0 billion five-year revolving credit facility on April 7, 2026, replacing its 2022 credit agreement, which had no borrowings outstanding when terminated. MPLX, its sponsored partnership, signed a separate $2.5 billion five-year revolver the same day, replacing its $2.0 billion 2022 facility. The filing reports no current borrowings under either new facility and no earnings results, only a preliminary cash figure.
MPC's new $5.0 billion unsecured revolving credit facility matures on April 7, 2031, with an option to add up to $1.0 billion in commitments.
MPLX's new $2.5 billion unsecured revolving credit facility also matures on April 7, 2031.
MPC must keep its Consolidated Net Debt to Total Capitalization ratio at or below 65% at each fiscal quarter end.
As of March 31, 2026, MPC had $2.2 billion of cash and cash equivalents, including $1.5 billion held by MPLX.
On April 9, 2026, Bloom Energy issued Oracle Corporation a fully vested warrant to buy up to 3,531,073 Class A common shares at $113.28 per share, which was the October 28, 2025 closing price. The warrant can be exercised until 5:00 p.m. Eastern on October 9, 2026, by cash payment or cashless exercise. The warrant is tied to the companies' partnership to provide on-site solid state power for AI data centers, and any shares issued on exercise would add to Bloom's outstanding Class A shares.
Warrant covers up to 3,531,073 Class A common shares at an exercise price of $113.28 per share
Warrant issued April 9, 2026; fully vested and exercisable until 5:00 p.m. Eastern on October 9, 2026
Oracle may exercise by cash payment or cashless exercise; the warrant carries anti-dilution adjustments and registration rights
Issued under the Section 4(a)(2) registration exemption, tied to the Oracle partnership first disclosed October 30, 2025
Chemed Corporation renewed its $450 million senior secured credit facilities on April 10, 2026, under a Sixth Amended and Restated Credit Agreement. The five-year revolver uses a floating SOFR-based rate with a tiered spread tied to the company's leverage ratio, and includes an option to expand the revolver by an additional $250 million. The filing describes a renewal of existing financing rather than a change in reported results.
Five-year $450 million revolving credit facility, including $100 million for letters of credit
Floating rate generally based on SOFR plus a tiered rate that varies with the company's leverage ratio
Expansion feature allows Chemed to increase the revolver by an additional $250 million
JPMorgan Chase Bank, N.A. served as Administrative Agent; Bank of America, N.A. was Syndication Agent
AdaptHealth and its subsidiary AdaptHealth LLC entered a credit agreement dated April 10, 2026, with Bank of America as administrative agent, and used it to repay the prior credit agreement from January 20, 2021. The new facility provides $450 million of revolving commitments, $325 million of initial term loans and $325 million of delayed draw term loans, and matures in April 2031. The company says the new terms carry lower pricing, and it does not expect the transaction to affect its full-year 2026 guidance.
Facility includes $450 million in revolving commitments, $325 million in initial term loans and $325 million in delayed draw term loans available for up to two years after closing.
Credit agreement dated April 10, 2026; scheduled maturity April 13, 2031, subject to a springing maturity 91 days before the 2028 Senior Notes mature if more than $15 million remains outstanding.
Proceeds repaid the prior credit agreement with Regions Bank; the company says the lowest pricing tier fell from 1.50% to 1.125% over SOFR.
The company does not expect the transaction to affect full-year 2026 guidance issued February 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.